Insider · CIK 0001453524
Jonathan P. DiVincenzo
coopresidentofficer
Files at BIO (BIO-RAD LABORATORIES, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 5, 2026 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Bio-Rad A Common Stock | +1,712 | $0.00 | $0 | 2,631 | 33 d ago |
| Sep 5, 2026 | BIO BIO-RAD LABORATORIES, INC. | FTax withholding Bio-Rad A Common Stock | -668 | $386.11 | $258k | 1,963 | 33 d ago |
| Sep 4, 2026 | BIO BIO-RAD LABORATORIES, INC. | AGrant or award Restricted Stock Unitsderivative | +6,326 | $0.00 | $0 | 6,326 | 33 d ago |
| Sep 5, 2026 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Restricted Stock Unitsderivative | -1,712 | $0.00 | $0 | 5,138 | 33 d ago |
| Oct 24, 2025 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Bio-Rad A Common Stock | +1,869 | $0.00 | $0 | 1,869 | Oct 28, 2025 |
| Oct 24, 2025 | BIO BIO-RAD LABORATORIES, INC. | FTax withholding Bio-Rad A Common Stock | -950 | $339.75 | $323k | 919 | Oct 28, 2025 |
| Oct 24, 2025 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Restricted Stock Unitsderivative | -1,869 | $0.00 | $0 | 5,609 | Oct 28, 2025 |
| Sep 5, 2025 | BIO BIO-RAD LABORATORIES, INC. | AGrant or award Restricted Stock Unitsderivative | +6,850 | $0.00 | $0 | 6,850 | Sep 9, 2025 |
| Mar 3, 2025 | BIO BIO-RAD LABORATORIES, INC. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +4,863 | $0.00 | $0 | 4,863 | Mar 5, 2025 |
| Oct 24, 2024 | BIO BIO-RAD LABORATORIES, INC. | AGrant or award Restricted Stock Unitsderivative | +7,478 | $0.00 | $0 | 7,478 | Oct 25, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.